GlobalFoundries stock saw big gains this week in conjunction with the announcement of new quantum computing initiatives and ...

Whether you're playing catch-up with your retirement account or simply enjoy working, remaining on the job past full ...

At 18 times operating cash flow, Microsoft hasn't been this cheap since 2019. That's a historical sell-off and lends credence ...

The idea of filing for benefits as soon as you're eligible sounds great... until you really start looking at the numbers.

If they left that money to you, it might seem like the simplest thing to do is roll it into your own IRA. This is definitely ...

The Saver's Match was created as part of the SECURE 2.0 Act, passed at the end of 2022, but it's not scheduled to take effect ...

Doximity stock has gotten clobbered this year, down 56%. Here's the short thesis for why I think the market's reaction is ...

The companies within the S&P 500 are among the largest and strongest in the U.S., making this ETF more likely to recover from ...

The amount of money that the some companies are spending on artificial intelligence (AI) infrastructure is jaw-dropping.

Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary ...

This biotechnology firm develops clinical-stage therapies for autoimmune and neuroinflammatory diseases using proprietary TYK2 inhibitors.

At the end of 2025, Warren Buffett stepped down from the post of CEO of Berkshire Hathaway (BRKA +1.43%) (BRKB +1.32%) -- the ...